These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 19800113

  • 1. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
    Morille M, Montier T, Legras P, Carmoy N, Brodin P, Pitard B, Benoît JP, Passirani C.
    Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L, Tian B, Li Y, Lei T, Meng J, Yang L, Zhang Y, Chen F, Zhang H, Xu H, Zhang Y, Tang X.
    ACS Appl Mater Interfaces; 2015 Nov 18; 7(45):25147-61. PubMed ID: 26501354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
    Jestin E, Mougin-Degraef M, Faivre-Chauvet A, Remaud-Le Saëc P, Hindre F, Benoit JP, Chatal JF, Barbet J, Gestin JF.
    Q J Nucl Med Mol Imaging; 2007 Mar 18; 51(1):51-60. PubMed ID: 17372573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
    Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y, Ueno M, Kobayashi H, Kikuchi H, Harashima H.
    Gene Ther; 2007 Jan 18; 14(1):68-77. PubMed ID: 16915290
    [Abstract] [Full Text] [Related]

  • 15. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
    Resnier P, David S, Lautram N, Delcroix GJ, Clavreul A, Benoit JP, Passirani C.
    Int J Pharm; 2013 Oct 01; 454(2):748-55. PubMed ID: 23583841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
    Resnier P, LeQuinio P, Lautram N, André E, Gaillard C, Bastiat G, Benoit JP, Passirani C.
    Biotechnol J; 2014 Nov 01; 9(11):1389-401. PubMed ID: 25262914
    [Abstract] [Full Text] [Related]

  • 18. The adaptation of lipid nanocapsule formulations for blood administration in animals.
    Hureaux J, Lagarce F, Gagnadoux F, Clavreul A, Benoit JP, Urban T.
    Int J Pharm; 2009 Sep 11; 379(2):266-9. PubMed ID: 19467305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.